Table 2.
Groups | n | Mean survival period (mo) | t | P | 5-yr survival rate (%) | χ2 | P | |
Integrin β3 mRNA | - | 56 | 38.46 ± 29.20 | 2.27 | < 0.05 | 71.4 (40/56) | 5.60 | < 0.05 |
+ - +++ | 62 | 27.18 ± 24.73 | 11.3 (7/62) | |||||
VEGF | - | 54 | 41.70 ± 30.62 | 3.40 | < 0.01 | 70.4 (16/54) | 6.52 | < 0.05 |
+ - +++ | 64 | 24.80 ± 21.78 | 10.9 (7/64) | |||||
MVD (n/mm2) | < 54.90 | 47 | 44.70 ± 32.05 | 3.84 | < 0.01 | 63.8 (17/47) | 13.85 | < 0.01 |
≥ 54.90 | 71 | 24.48 ± 20.40 | 8.5 (6/71) |